Tag Archives: partial-onset seizures

October, 2018

May, 2018

October, 2016

May, 2016

  • 2 May

    FDA Approves Oral Suspension Formulation of Eisai’s Fycompa

    WOODCLIFF LAKE, N.J., May 2, 2016 /PRNewswire/ — Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved FYCOMPA® (perampanel) CIII Oral Suspension as adjunctive therapy for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures, and primary generalized tonic-clonic (PGTC) seizures in …